TRANSTHYRETIN AMYLOID CARDIOPATHY
Clinical trials for TRANSTHYRETIN AMYLOID CARDIOPATHY explained in plain language.
Never miss a new study
Get alerted when new TRANSTHYRETIN AMYLOID CARDIOPATHY trials appear
Sign up with your email to follow new studies for TRANSTHYRETIN AMYLOID CARDIOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Withdrawn heart drug trial aimed to slow deadly protein buildup
Disease control TerminatedThis study aimed to see if a drug called ION-682884 could slow or stop the progression of a serious heart condition called TTR amyloid cardiomyopathy. The drug was designed to reduce the production of a harmful protein that builds up in the heart. The trial was only for a small g…
Matched conditions: TRANSTHYRETIN AMYLOID CARDIOPATHY
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Scientists track Real-World journey of rare heart disease patients
Knowledge-focused OngoingThis study aims to understand how a rare heart condition called ATTR-CM is managed in real-world medical practice. Researchers will observe and collect data from about 350 patients in Taiwan, Hong Kong, and Malaysia who have already been diagnosed. The study does not test any new…
Matched conditions: TRANSTHYRETIN AMYLOID CARDIOPATHY
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:57 UTC